← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Elixera, Inc.
Redwood City, CA
$2,604,127
Total funding
3
Grants
Funding over time
peak $1.1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,604,127 · 3
By mechanism
R44$2,095,403 · 1
R43$508,724 · 2
Investigators at Elixera, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
A First-in-Class Therapeutic Antibody for Treatment of Acromegaly$1,059,814
R44 · FY2025 · DK
A First-in-Class Therapeutic Antibody for Treatment of Acromegaly$1,035,589
R44 · FY2024 · DK
A First-in-Class Antibody Therapeutic for Treatment of Acromegaly$284,100
R43 · FY2020 · DK
A First-in-Class Human Antibody Therapeutic for Treatment of Cushing's Disease$224,624
R43 · FY2019 · DK